VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	10/30/2001 12:33:10 PM
From: scaram(o)uche	of 269

Rick Shea's presentation at that Massachooosuts meeting is very well done. He clearly outlines the company's objectives and direction. He emphasized elements that show breadth in the business plan, but gave good weighting -- IMO -- to (1) genome-wide LOH maps as a focus of the cancer program, and (2) the leg up that methods such as those described by Chasman and Adams will give the company. I'm not pleased that the company has failed miserably to meet this year's objectives, but it is clearly presented that they're moving aggressively to a new business plan, supported by the old one. Me <------- only modestly disgruntled camper

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next